A NETWORK OF LOYAL PARTNERS
A proximity partnership
Lemer Pax provides its long-standing partner Confluent with its new equipment dedicated to the services of Nuclear Medicine. In this context, the test phase for our Posijet® injector was validated by our partner. At the same time, Confluent appreciated the benefits of the new injector, both for patients and carers. This allowed us to strengthen our proximity links and reassert our local presence.
At the service of nuclear cardiology
The Quanticardi project reflects the determination to move from theory to practice at the service of nuclear cardiology. Nantes University, the public interest group Arronax, Keosys and Lemer Pax, grouped together within the Atlanpôle Biothérapies, joined forces to propose a new-generation approach to cardiac imaging. This association of skills led to the creation of the company Naogen Pharma.
New Materials
Seven years ago, Lemer Pax set up a partnership with the Nantes Institute of Materials (IMN) to develop a range of new materials intended for radiation protection. The R&D department has prototyped, in particular, a material based on nanotechnology.
An injector for epilepsy
In collaboration with Dr Setoain from the Hospital Clinic of Barcelona, the Epijet project has developed a specific radiopharmaceutical injector whose objective is to locate, in patients suffering from epilepsy, the area of the brain responsible for the fit. Lemer Pax has therefore developed an injector which it produces and distributes.
Bpifrance supports innovation and internationalisation at Lemer Pax in collaboration with the Region and the private players. Lemer Pax is a member of the Bpifrance Excellence club which includes companies whose export growth perspectives seem promising. Lemer Pax can therefore benefit from high-quality services including special training and networking.
In 2013, Pierre-Marie Lemer was awarded the INPI Innovation Trophy and travelled with the delegation accompanying French President of François Hollande on a state visit to India. During this presidential trip, surrounded by France’s CAC-40 companies, Lemer Pax consolidated its reputation and strengthened its position in this strategic area, in particular through a distribution agreement in the field of nuclear medicine.
France
